Clinical trials
Pancreatic cancer clinical trials
Cancer that begins in the tissues of the pancreas. We’re tracking 719 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02598349RecruitingPhase 2
Proton radiation for pancreas cancer that can’t be removed
This trial tests proton radiation for people with pancreas cancer that cannot be fully removed by surgery (or who choose not to have surgery). It may help shrink or control the cancer using a treatment that aims to better target the tumor while limiting dose to nearby organs.
Jacksonville, FloridaAges 18 years+ - NCT03260842Recruiting
Biobank study for people at high risk of pancreatic cancer
This study collects and stores samples (bio-specimens) from adults who have pancreas cysts and are at higher risk for pancreatic cancer. The goal is to help researchers improve early detection so future patients may be diagnosed sooner.
Stanford, CaliforniaAges 18 years+ - NCT07591571Recruiting
Digital support program for newly diagnosed pancreatic cancer
This study tests a digital support program led by community health workers for people recently diagnosed with pancreatic adenocarcinoma (a type of pancreatic cancer). The program aims to help patients navigate their diagnosis and treatment.
Loma Linda, CaliforniaAges 1.5 years+ - NCT07647250Recruiting
Physical activity study for pancreatic cancer patients before surgery
This study tests if a personalized physical activity program can help pancreatic cancer patients who are receiving chemotherapy before surgery. It is designed for patients who feel weak or have early signs of frailty.
Chicago, IllinoisAges 18 years+ - NCT07155616Enrolling by invitation
Blood flow measurement from CT scan before Whipple surgery
This study uses a computer tool to measure blood flow in the arteries from your CT scan before a Whipple procedure. It may help doctors better plan your surgery.
Barcelona, BarcelonaAges 18 years+ - NCT06574373Recruiting
Finding new markers for pancreatic IPMN progression
This study looks for new markers in the blood or tissues of people with a pancreatic condition called IPMN. The goal is to find better ways to predict if IPMN might turn into cancer and to help choose the best treatment.
RomaAges 18 years+ - NCT05746182Recruiting
Genetic testing program for pancreatic neuroendocrine tumors
This study offers genetic (inherited) testing for people with pancreatic neuroendocrine neoplasms. The goal is to see who may have a genetic predisposition, which can help guide medical care and family risk.
Los Angeles, CaliforniaAges 18 years+ - NCT07432633RecruitingPhase 1/Phase 2
Imaging scan to detect cancer-linked protein in several tumor types
This trial tests a new PET scan tracer that targets a protein found on certain cancer cells. It may help doctors better see and understand tumors in people with colorectal, gastric, pancreatic, lobular breast, or ovarian cancer.
Dallas, TexasAges 18–80 - NCT04389632RecruitingPhase 1
Sigvotatug vedotin for advanced solid tumors that spread
This early-stage study tests a drug called sigvotatug vedotin in people with advanced solid cancers that cannot be removed or have spread. It aims to see how well the treatment works and what side effects it causes.
Anchorage, AlaskaAges 18 years+ - NCT07620574Enrolling by invitationPhase 3
Long-Term Study Continuing Cancer Treatment from Previous Trial
This study lets people who were in an earlier Exelixis cancer treatment trial continue receiving the same treatment if it's still helping them. It's designed to see how safe and effective the treatment is over a longer period.
Bay Shore, New YorkAges Any age - NCT05679674Recruiting
Radiation plus at-home tumor device for locally advanced pancreatic cancer
This trial tests whether combining targeted radiation with an at-home “tumor treating fields” device can better control locally advanced pancreatic cancer. It may help by attacking cancer cells in more than one way after prior chemotherapy.
Miami, FloridaAges 18 years+ - NCT04999761RecruitingPhase 1
Study testing new drug combinations for advanced cancers
This study tests new drug combinations for people with various advanced cancers that have progressed after standard treatment, or in some cases, as a first treatment. It aims to see if these combinations are safe and effective. The study is divided into groups based on cancer type and treatment history, so not everyone will qualify for every group.
AichiAges 18 years+ - NCT06380816RecruitingPhase 1/Phase 2
Study of UCB4594 for advanced cancers with HLA-G marker
This trial tests an experimental drug called UCB4594 for people with certain advanced cancers that have not responded to standard treatments. The goal is to see if the drug is safe and effective against tumors that have a specific marker called HLA-G.
LondonAges 18 years+ - NCT07629960RecruitingPhase 1/Phase 2
New KRAS-Targeting Drug for Advanced Solid Tumors
This early-stage trial tests BLU-924, a new drug designed to target cancer cells with specific KRAS mutations (a common genetic change in pancreatic, lung, and colon cancers). The study aims to find the right dose and see how well it works in patients whose cancers have progressed despite standard treatments.
Sarasota, FloridaAges 18 years+ - NCT03484299RecruitingPhase 1
Study chemo plus irreversible electroporation for stage III pancreatic cancer
This early study tests a combination of chemotherapy and a procedure called irreversible electroporation (IRE) for people with stage III pancreatic cancer. It may help shrink or control tumors, and also studies safety in this group.
Louisville, KentuckyAges 18 years+ - NCT05241249RecruitingPhase 2
Bethanechol plus chemotherapy for pancreatic cancer
This trial tests whether adding bethanechol to standard chemotherapy (gemcitabine and nab-paclitaxel) can work better for people with pancreatic ductal adenocarcinoma. You may be considered if your cancer is not spread and you can safely take the medicines and follow study visits.
New York, New YorkAges 18 years+ - NCT05245877RecruitingPhase 4
Preventing blood clots before and after pancreatic surgery
This study compares two approaches to preventing blood clots around the time of pancreatic surgery. It may help lower the risk of dangerous clotting events after surgery, especially for people who are high risk.
TorontoAges 18–120 - NCT06046794Recruiting
Gemcitabine for metastatic pancreatic cancer patients
This trial tests gemcitabine chemotherapy in people with metastatic pancreatic cancer who cannot take FOLFIRINOX. It aims to see how well gemcitabine works based on a specific tumor marker called GemCore.
MarseilleAges 18 years+ - NCT06344507Recruiting
Registry of Pancreas and Bile Duct Endoscopy Procedures
This study collects pictures and information from people who have a routine endoscopic ultrasound to look at the pancreas and bile ducts. It aims to learn more about these conditions and improve future care.
MilanAges 18 years+ - NCT07458347RecruitingPhase 1
A new oral drug for KRAS-mutated advanced cancer
This trial tests a new oral drug, KST-6051, for people with advanced solid tumors (like lung, pancreatic, colon, or other cancers) that have a specific KRAS gene mutation. The goal is to find the best dose and see if it's safe.
Los Angeles, CaliforniaAges 18 years+ - NCT07262957RecruitingPhase 4
Preventing complications after pancreatic surgery with a drug bundle
This trial tests whether giving a combination of three treatments—hydrocortisone (a steroid), octreotide (a drug that reduces digestive fluids), and a tissue patch—before and during pancreatic surgery can help prevent complications. It is for people with a very small pancreatic duct (3 mm or less) who are scheduled for pancreatic surgery.
AmsterdamAges 18 years+ - NCT06076252Enrolling by invitation
Comparing two surgical methods for pancreatic cancer
This trial compares a modified surgical technique to the standard one for removing pancreatic tumors. It aims to see if the new method lowers the risk of a leak from the pancreas after surgery.
Zhanjiang, GuangdongAges 18–75 - NCT06519500Recruiting
Growing tumor models from gastrointestinal neuroendocrine tumor surgery
This study takes tumor tissue from people having surgery for a certain type of gut or pancreas cancer (neuroendocrine tumors). The tissue is used to grow tiny 3D models called organoids in the lab, which can help researchers learn more about the tumor and find better treatments.
RomeAges 18 years+ - NCT07224750Recruiting
A blood test to find early signs of gastrointestinal cancer
This study is testing a blood-based test to detect unique molecules (called miRNAs) that may signal the presence of several types of gut or digestive system cancers. The goal is to develop a simple screening tool that could catch these cancers earlier.
Duarte, CaliforniaAges 18 years+
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pancreatic cancer?
- Yes. Clin2 currently lists 719 recruiting pancreatic cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pancreatic cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pancreatic cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.